- Clopidogrel 75mg — stents
- Atorvastatin 20mg twice daily + Ezetimibe 10mg
- Bisoprolol, lercanidipine, allopurinol
- Stopped: apixaban, aspirin, clindamycin, colchicine
- Anaemia recovering — Hb 125 (12 Oct); colonoscopy Dec
- L knee osteitis — CRP normal (<0.5, 12 Oct), off antibiotics
- DVT — apixaban stopped Oct; follow-up doppler Dec
- 3-vessel CAD — 3 stents (RCA Jul 2026; left main + LAD Aug 2026)
- Hypertension, gout, hiatus hernia
- R hip replacement 2018
- L knee septic arthritis + osteitis (Jun 2026)
- DVT L calf (Jul 2026)
- Scalp psoriasis/eczema
- Family: father/brother cardiac; mother leukaemia; sister colon cancer
ADR: piperacillin/tazobactam — hepatotoxic reaction, avoid in future. Details →
- Colonoscopy — December 2026
- DVT follow-up venous doppler — December 2026
- PSA — annual (next due ~Nov 2026)
- Lipid panel post-PCI — none on file
- DTP, pneumococcal, 2nd shingles dose
1. Outstanding Health Issues
Open items as of 19 October 2026| Issue | What's needed |
|---|---|
| DVT follow-up doppler — December 2026 | Isolated distal DVT, left fibular vein (7.5mm, provoked), found 10 Jul 2026. Apixaban was stopped at the 3-month mark in Oct 2026. The repeat doppler due ~10 Oct was cancelled and rebooked for December to confirm the clot has resolved. |
| Colonoscopy — December 2026 | Indications: iron-deficiency component to the anaemia while on antithrombotics, sister with colon cancer, polyp removed Dec 2022 (pathology not on file). Antithrombotic plan around the procedure to be agreed with cardiology. |
| Anaemia — recovering | Hb 103 (4 Sep) → 116 (22 Sep) → 125 g/L (12 Oct), reference 129–167. Aug workup showed a mixed picture: inflammation plus true iron deficiency. Repeat FBC and iron studies to confirm full recovery; colonoscopy outstanding. |
| Left knee osteitis — CRP normalised | MSSA septic arthritis (Jun 2026) with osteitis of the medial tibial plateau on CT (19 Aug 2026). CRP <0.5 on 12 Oct 2026 (23.1 on 19 Aug). Clindamycin stopped. Follow-up plan after treatment not yet recorded here. Separate pre-existing tricompartmental osteoarthritis. |
| Lipids — no post-PCI panel on file | On atorvastatin 20mg twice daily + ezetimibe 10mg. Target LDL-C <1.4 mmol/L (<55 mg/dL) and ≥50% reduction from baseline. Repeat fasting lipid panel. |
| ECG machine read "old infarct(s)" (6 Aug 2026) | The PDF was unreadable (scanned image) so this was never checked against a cardiologist's interpretation. Ask at the next cardiology review. |
| Immunisations behind | DTP not up to date, no pneumococcal vaccine ever, shingles 1 of 2 doses (2025) — see Medications, Allergies & Immunisations. |
2. Treatment & Rehab Goals
3. Upcoming Appointments
As of 19 October 2026Prevention
Targets and tracking — "TBC" means no data on file yetCARDIOVASCULAR HEALTH
| Measure | Where he is now | Target |
|---|---|---|
| Cholesterol (LDL-C) On atorvastatin 20mg twice daily + ezetimibe 10mg |
Controlled? TBC. No lipid panel on file since the PCIs and the dose increase. | LDL-C <1.4 mmol/L (<55 mg/dL) and ≥50% reduction from baseline (ESC/EAS very-high-risk). Repeat fasting panel; if above target on this regimen, discuss adding a further agent. |
| Blood pressure On lercanidipine 10mg + bisoprolol 2.5mg |
Controlled? TBC. No home readings on file. Last recorded: 160/80 at cardiology, 18 Jun 2026 (in pain, acutely unwell, so not representative). | Below 140/90 at minimum; systolic 120–129 if tolerated (ESC 2024). Home BP for 7 days (two readings morning and evening) to check control. |
| BMI / body fat Withings |
TBC from Withings. Hospital records: 80 kg, BMI 26.4 (23 Jun 2026); 77.6 kg, BMI 25.3 (15 Jul 2026). | BMI 22–26, stable weight; body-fat % and waist to be set once Withings data is in. |
| VO2max Fitbit cardio fitness score |
TBC from Fitbit. | Steady rise from baseline through cardiac rehab and regular cycling. |
CANCER SCREENING
| Screen | Last done | Result | Status |
|---|---|---|---|
| Colorectal (colonoscopy) | Dec 2022 — Clinique d'Orange, Dr Rabbia | Diverticulosis + polyp removed. Polyp pathology/size not in the records reviewed. | Lined up for December 2026. Reasons: sister with colon cancer, previous polyp, and an iron-deficiency component to the anaemia while on antithrombotics. |
| Prostate | PSA Nov 2025 — 1.39 µg/L (normal, <4) | Feb 2026 ultrasound referral for dysuria/nocturia — outcome not found in folder. CT Aug 2026 reassuring for the pelvis. | Annual PSA — next due ~Nov 2026. At 75 this is an individual decision rather than organised screening; keep the LUTS follow-up in view. |
No other organised screening is documented beyond the dermatology visits covered under Past Medical History.
MUSCULOSKELETAL HEALTH — FIVE MOBILITY TESTS
| Ability | Now | Target | Why it matters |
|---|---|---|---|
| 1. Dead hang (both hands, overhead bar) | TBC — time in seconds | 30 s; longer-term 60 s | Grip, shoulder health and thoracic extension (kyphosis). Breathe normally, no breath-holding, stop for chest symptoms. |
| 2. Squat — depth and knee range of motion | TBC. Left knee flexion was painful at 90° on admission (23 Jun 2026); no measurement since. | Pain-free bodyweight squat to parallel; left knee flexion ≥120°, full extension (0°), matching the right | Getting up from low seats and the floor; tracks recovery of the left knee after infection and OA. |
| 3. 30-second sit-to-stand | TBC — repetitions | ≥15 reps (age-norm cut-off for men 75–79 is about 11) | Lower-limb power and independence. |
| 4. Single-leg balance (eyes open) | TBC — seconds each leg | ≥30 s each leg; under 5 s means high fall risk | Falls and bleeding risk while on blood thinners; matters for outdoor cycling. |
| 5. Thoracic extension / posture (back-to-wall) | TBC — head-to-wall distance with heels and back against the wall (cm) | 0 cm | Kyphosis noted through the illness; track with rows, prone extensions and wall angels. |
MENTAL HEALTH
| Domain | Where he is now | Target |
|---|---|---|
| Sleep quality Fitbit |
TBC from Fitbit (duration, efficiency, awakenings). Using Quviviq 50mg at night since Jul 2026. | 7+ hours most nights and a stable pattern; review the need for Quviviq with Dr Paur once sleep settles. |
| Mood and stress | Cardiac diagnosis, three stents and a serious knee infection, all within about two months. | Regular check-in on mood and on processing these events; GP review if low mood or anxiety persists. |
| Alcohol | Baseline about 2 beers + 2 glasses of wine a day (roughly 28 standard drinks a week); sharply lower since hospitalisation. | Within the French guideline of no more than 10 standard drinks a week, with alcohol-free days. |
| Fun and normal life | Cycling in the countryside, squash and gardening are the usual outlets; currently limited. | Rebuild these gradually, starting with cycling once cleared. |
Immunisations have their own tab — see Medications, Allergies & Immunisations.
Past Medical History
Compiled from hospital records & referral letters| Condition | When / Detail |
|---|---|
| Coronary artery disease (3-vessel) — 3 stents | Angiography 7 Jul 2026 (left main ~80%, mid-LAD 60%, mid-RCA 80%; SYNTAX 24). PCI in two sessions: 29 Jul 2026 — mid-RCA, Orsiro 3.5×30mm drug-eluting stent; 6 Aug 2026 — rotational atherectomy of the distal left main, then Xience Skypoint 3.5×33mm (left main) and 3×38mm (mid-LAD), kissing balloon to the circumflex. Complete revascularisation. LVEF 80% (echo 18 Jun 2026). |
| Septic arthritis, left knee (MSSA) + osteitis | Pain from 12 Jun 2026; admitted 23 Jun 2026. Washouts 26 Jun and 3 Jul 2026. CT 19 Aug 2026 confirmed osteitis of the medial tibial plateau (two erosive geodes, 12mm and 5mm). Clindamycin, then stopped; CRP <0.5 on 12 Oct 2026. |
| DVT, left calf (fibular vein), provoked | Found 10 Jul 2026 — apixaban Jul–Oct 2026 (stopped at 3 months); follow-up doppler December 2026 |
| Anaemia (inflammation + iron deficiency) | From Jun–Jul 2026, Hb nadir 88–89 g/L (Jul–Aug 2026); 125 g/L on 12 Oct 2026 |
| Osteoarthritis, left knee (tricompartmental) | Found on X-ray 19 Aug 2026 (unchanged from an older film) — pre-existing and separate from the infection |
| Hypertension | 20+ years (month not recorded) — lercanidipine + bisoprolol |
| Gout | 30+ years (month not recorded) — allopurinol long term. Colchicine trialled Jun–Aug 2026 during the knee episode and stopped Aug 2026; no crystals were ever found. |
| Scalp psoriasis/eczema | Longstanding; multiple topical courses with limited success. Dermatology review 27 Jul 2026 (Aix). Current: desloratadine daily and emollients; biologic considered later |
| Lower urinary tract symptoms | Dysuria/nocturia — prostate ultrasound referral Feb 2026 (Dr Maclet); outcome not found in folder. PSA Nov 2025 normal |
| Popliteal cyst, ruptured | Jun 2026 — suspected by Dr Unal on 18 Jun 2026, before septic arthritis was found |
| Right total hip replacement | 2018 (month not recorded), for osteoarthritis |
| Diverticulosis + colonic polyp (removed) | Colonoscopy Dec 2022, Clinique d'Orange (Dr Rabbia). Repeat colonoscopy December 2026 |
| Hiatus hernia | Endoscopy 2022 (month not recorded) |
| Right inguinal hernia repair ×2 | Two separate procedures, dates not recorded |
| Tonsillectomy | Age 5 |
FAMILY HISTORY
| Relative | Condition |
|---|---|
| Father and brother | Cardiac disease |
| Mother | Leukaemia (deceased) |
| Sister | Colon cancer — under treatment (per the Jul 2026 discharge letter) |
Compiled from discharge summaries and referral letters in the Drive folder — not a substitute for the full GP record. Flag anything missing or inaccurate.
Current Medications
As of 19 October 2026| Drug | Indication | What it does | When | Until |
|---|---|---|---|---|
| Clopidogrel 75mg | Antiplatelet — protects the 3 coronary stents | Stops platelets clumping on the stents | 8am | Per cardiology (Dr Quillot) |
| Allopurinol — TWO 100mg tablets together, once daily | Gout prophylaxis | Gout prevention (long-standing) | 6pm — 2 tablets together (200mg) | Long term |
| Atorvastatin 20mg — one tablet twice daily | Hyperlipidaemia — secondary prevention post-PCI | Statin — lowers cholesterol and stabilises artery narrowings. 40mg/day in total. | 8am · 6pm | Long term |
| Ezetimibe 10mg | Hyperlipidaemia — secondary prevention post-PCI | Blocks cholesterol absorption — added to the statin for extra LDL lowering | Evening | Long term |
| Bisoprolol 2.5mg | Cardioprotection / rate control | Beta-blocker — reduces heart rate and workload | 8am | Long term |
| Colécalciférol (Vitamin D) 2,500 IU | Vitamin D deficiency | Vitamin D — levels were low on admission | Daily | Ongoing |
| Desloratadine (Aerius) 5mg | Pruritus (dermatologist-prescribed) | Antihistamine — daily and non-negotiable per rehab goals | Evening, daily | Ongoing |
| Emollient (unspecified) | Skin barrier / general skin care | Skin barrier support | 3 times daily + after every shower | Ongoing, non-negotiable |
| Fer (Iron) | Iron deficiency (anaemia) | Iron supplement — dose and frequency to be confirmed | To confirm | To confirm |
| Lercanidipine 10mg | Hypertension | Blood pressure (long-standing) | 8am | Long term |
| Pantoprazole 40mg | Gastroprotection | Stomach protector — prevents ulcers | 6pm | Originally 30 days — review with Dr Paur |
| Paracetamol (Doliprane) — TWO 500mg tablets together | Analgesia / antipyretic, as needed | Pain relief / fever — as needed | Every 8 hours if needed — 2 tablets together (1g) | As needed |
| Quviviq (daridorexant) 50mg | Insomnia | Sleep aid — started ~16-17 Jul 2026 for stress-related insomnia and oxazepam withdrawal | 30 min before bed | Ongoing — review with Dr Paur |
| Vitamine B12 | Anaemia work-up / supplementation | Vitamin B12 supplement — dose and frequency to be confirmed | To confirm | To confirm |
Stopped: apixaban (Oct 2026, at the 3-month mark), aspirin (14 Aug 2026), clindamycin, colchicine (Aug 2026). Stock counts have been removed because the last count (15 Aug) is out of date — send a fresh count to add them back.
Allergies & Adverse Drug Reactions
Immunisations
Now documented — from full 15 Jul discharge letter| Vaccine | Status |
|---|---|
| Influenza | Up to date |
| COVID-19 | Up to date |
| Shingles (VZV) | 1 of 2 doses given, 2025 — likely overdue for the second dose if this was a 2-dose series (e.g. Shingrix, usually 2-6 months apart) |
| DTP (diphtheria/tetanus/polio) | Not up to date — booster needed |
| Pneumococcal | Never vaccinated — worth prioritising given age 75 and recent hospitalisations |
Documents & Lab Results
Labs first, then documents · Tap to open · Google DriveBlood Test Results
Latest: 12 Oct 2026| Test | Normal | 24 Jun | 26 Jun | 28 Jun | 30 Jun | 1 Jul | 3 Jul | 5 Jul | 7 Jul | 9 Jul | 13 Jul | 15 Jul | 22 Jul | 27 Jul | 3 Aug | 12 Aug | 19 Aug | 4 Sep* | 22 Sep* | 12 Oct ↑ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRP (mg/L) Infection marker |
<5 | 149 | 192 | 235 ▲ | 206 | 207 | 200 | 120 ▼ | 44.8 ▼ | 43.1 | 39.4 ▼ | 36.2 ▼ | 28.3 ▼ | 41.1 ▲ | 27.3 ▼ | 14.6 ▼ | 23.1 ▲ | 0.6 | 6.4 ▲ | <0.5 ▼ ✓ |
| Haemoglobin (g/L) Anaemia |
129–167 | 121 | 119 | 118 | 107 | 100 | 104 | 99 | 94 ▼ | 89 ▼ | 93 ▲ | 88 ▼ | 100 ▲ | 102 | 93 ▼ | 89 ▼ | 89 → | 103 | 116 ▲ | 125 ▲ |
| WBC (G/L) White cells |
3.84–9.80 | 10.1 | 9.34 | 10.5 | 11.1 | 9.71 | 9.11 | 7.63 | 6.41 ▼ | 7.95 | 6.65 ▼ | 6.04 ▼ | 7.26 | 7.81 | 6.27 ▼ | 5.98 ▼ | 6.40 ▲ | — | — | 5.22 |
| Platelets (G/L) Clotting |
140–385 | 384 | 479 | 520 | 548 | 536 | 589 | 574 | 547 | 543 | 520 ▼ | 458 ▼ | 417 ▼ | 401 ▼ | 363 ▼ | 349 ▼ | 375 ▲ | 281 | 164 | 202 |
| eGFR (mL/min) Kidney function |
>90 | 76 | 58 | 61 | 65 | 66 | 71 | 70 | 62 | 60 | 73 | 74 | 67 ▼ | 72 ▲ | — | 73 ▲ | 67 ▼ | — | — | — |
| Creatinine (µmol/L) Kidney marker |
64–104 | 86 | 107 | 103 | 98 | 97 | 91 | 92 | 102 | 105 | 89 ▼ | 88 ✓ | 96.3 | 90.2 ✓ | — | 88.4 ✓ | 96.2 ✓ | — | — | — |
| GGT (U/L) Liver enzyme |
10–71 | 131 | 139 | 635 ▲▲ | 341 | 258 | 632 ▲▲ | 581 | 332 ▼ | 239 ▼ | 146 ▼ | 114 ▼ | 79 ▼ | — | — | — | 61 ✓ | — | — | — |
| AST (U/L) Liver enzyme |
10–50 | 47 | 40 | 314 ▲▲ | 41 | 41 | 63 | 37 | 29 ✓ | 22 ✓ | 21 ✓ | 17 ✓ | 14 ✓ | — | — | — | 15 ✓ | — | — | — |
| ALT (U/L) Liver enzyme |
10–50 | 97 | 76 | 173 | 80 | 66 | 78 | 65 | 42 ✓ | 33 ✓ | 19 ✓ | 16 ✓ | 17 ✓ | — | — | — | Normal ✓ | — | — | — |
| INR Clotting |
0.8–1.2 | — | — | — | — | — | — | — | — | — | — | — | — | 1.40* | 1.42* | — | — | — | — | — |
Why are the liver enzymes elevated?
CARDIAC
Note: the original 7 July coronary angiogram report PDF itself hasn't turned up as a standalone file in the Drive folder — the anatomy (left main 70-90%, proximal LAD critical, mid-RCA 70-90%, SYNTAX 24) is documented in Dr Quillot's discharge summaries and referenced in Philip's 28 July letter. Worth uploading the standalone report if you have it.
KNEE INFECTION — MICROBIOLOGY
BLOOD CULTURES
BLOOD TEST RESULTS
DERMATOLOGY
DVT
PRE-ADMISSION HISTORY
APPOINTMENTS
Folder last synced 4 August 2026. Drop new files into the Drive folder and ask Claude to re-sync to add them here.
All Documents — Date Order
Most recent firstCompiled from the shared Drive folder as of 4 August 2026. Some exact duplicate uploads have been collapsed to one entry.
Full Timeline
Most recent firstCRP 28.3 mg/L — lowest since admission (was 235 at peak). Still elevated but continuing a consistent downward trend — the infection is resolving.
Liver enzymes almost normal — GGT 79 (nearly there), AST 14 ✓, ALT 17 ✓. The pip/tazo drug reaction has fully resolved.
Lymphocytes 1.42 — back in normal range. Immune system recovering.
eGFR 67 — slight dip from 74 last week. Ensure good hydration in the heat. Worth monitoring next week.
Monocytes 0.81 — still mildly elevated. Persistent but not worsening. Keep an eye on this over coming weeks.
Eosinophils 0.33 — unchanged. Drug reaction signal persisting but within normal range.
Diet Guidance
Cardiovascular optimisation| Current | Suggested swap / addition | Why |
|---|---|---|
| Granola | Plain porridge oats + fruit | Oat beta-glucan reduces LDL by ~5-10%. Commercial granola often high in sugar and palm oil. |
| Yellow fruit pot (syrup) | Berries or fruit in juice | Blueberries and raspberries have the best cardiovascular evidence — polyphenols, low sugar. |
| Taramasalata | Hummus or mashed avocado | Chickpeas = soluble fibre (lowers LDL). Avocado = monounsaturated fats + potassium. |
| White fish mainly | Oily fish 2–3x/week | Sardines, mackerel, salmon. Omega-3 lowers triglycerides. Tinned sardines = cheap and easy. |
| Milk chocolate | Dark chocolate 70%+ | Flavonoids in dark chocolate have genuine cardiovascular evidence. A few squares daily is fine. |
| — | Add: small handful of walnuts daily | Best nut for cardiovascular evidence. ALA omega-3. On porridge or as a snack. |
| — | Add: olive oil as main cooking fat | Monounsaturated, anti-inflammatory, Mediterranean diet evidence base (PREDIMED trial). |
| — | Add: lentils or beans 2x/week | Soluble fibre, plant protein, LDL lowering. Lentil soup is easy and cheap. |
Social History
Now documented — from full 15 Jul discharge letter